The Valley Desk

NCT02393625 · Interventional trial

Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer

Overall registry status Active not recruiting

Phase 1

Conditions ALK-positive NSCLC

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov